A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice.
Saved in:
| Title: | A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice. |
|---|---|
| Authors: | Emond C; BioSimulation Consulting Inc., Crabtree, QC, Canada. claude.emond@biosmc.com.; School of Public Health, Department of Environmental and Occupational Health, University of Montreal, Montreal, QC, Canada. claude.emond@biosmc.com., DeVito MJ; Center for Computational Toxicology and Exposure, Chemical Characterization and Exposure Division, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA., Birnbaum LS; Scientist Emeritus, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. |
| Source: | Archives of toxicology [Arch Toxicol] 2025 Mar; Vol. 99 (3), pp. 1043-1058. Date of Electronic Publication: 2025 Jan 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0417615 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0738 (Electronic) Linking ISSN: 03405761 NLM ISO Abbreviation: Arch Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0738 |
|---|---|
| DOI: | 10.1007/s00204-024-03939-4 |
